We note that mutations in beta-catenin, FBXW11’s substrate, have also been observed in colon cancer, where they affect Ser and Thr residues that are essential for the phosphorylation-dependent degradation of beta-catenin (67). Here, FBXW11 is linked to malignant colon neoplasm.